Transcription of Drug treatment for panic disorder with or without ...
{{id}} {{{paragraph}}}
Example: stock market
Drug treatment for panic disorder with or without ...
RESEARCHthe bmj | BMJ 2022;376:e066084 | doi: 1 Drug treatment for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trialsNatasha Chawla,1 Thunyarat Anothaisintawee,1,2 Kridsada Charoenrungrueangchai,1 Papan Thaipisuttikul,3 Gareth J McKay,4 John Attia,5 Ammarin Thakkinstian2 ABSTRACTOBJECTIVETo identify drug classes and individual selective serotonin reuptake inhibitors (SSRIs) with high rates of remission and low risk of adverse events in the treatment of panic disorder with or without review and network SOURCESE mbase, Medline, and from inception to 17 June CRITERIA FOR STUDY SELECTIONR andomised controlled trials that included adults aged 18 years with a diagnosis of panic disorder , compared drugs used to treat the panic disorder , and measured the outcomes of interest, including remissions, dropouts, and adverse of bias in the included studies was assessed using the revised Cochrane risk of bias tool for randomised trials.
also undertook a network meta-analysis to compare individual SSRIs (eg, fluoxetine, fluvoxamine, paroxetine, sertraline, escitalopram, and citalopram). Methods This systematic review and network meta-analysis was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (PRISMA).11 12
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: